甲狀腺髓質癌的標靶治療：探討藥物使用 Targeted Therapy for Medullary Thyroid Cancer

這段影片將介紹甲狀腺髓質癌的標靶治療方法，特別是使用Cabozantinib、Vandetanib、Selpercatinib和Pralsetinib等藥物。觀眾將了解這些標靶藥物如何針對RET突變和RAS突變進行治療，以及它們在治療中的應用和效果。

This video introduces the targeted therapy options for medullary thyroid cancer, focusing on the use of Cabozantinib, Vandetanib, Selpercatinib, and Pralsetinib. Viewers will learn how these targeted drugs address RET and RAS mutations, as well as their applications and efficacy in treatment.